Atlas Trials

Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)

Clinical trial NCT01716039 · TERMINATED

Trial details

NCT number
NCT01716039
Sponsor
Alimentiv Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2013-06-01
Primary completion
2016-07-18
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.